These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pharmacokinetic and pharmacodynamic properties of inhaled corticosteroids in relation to efficacy and safety. Derendorf H Respir Med; 1997 Nov; 91 Suppl A():22-8. PubMed ID: 9474364 [TBL] [Abstract][Full Text] [Related]
23. [Inhalatory corticosteroids in therapy of bronchial asthma]. Kosarev VV; Lotkov VS; Kuklin AS Ter Arkh; 2000; 72(8):59-61. PubMed ID: 11019432 [No Abstract] [Full Text] [Related]
26. Is long-term treatment with inhaled steroids in adults hazardous? Boe J; Skoogh BE Eur Respir J; 1992 Oct; 5(9):1037-9. PubMed ID: 1426211 [No Abstract] [Full Text] [Related]
27. Glucocorticosteroid treatment of asthma. Bai TR Can Fam Physician; 1995 Nov; 41():1921-7. PubMed ID: 8563509 [TBL] [Abstract][Full Text] [Related]
28. Assessment end points for inhaled drug delivery. Anderson PJ Respir Care; 2000 Jun; 45(6):737-55. PubMed ID: 10894464 [TBL] [Abstract][Full Text] [Related]
29. Inhaled beta-2 agonists and steroids. Present state and future perspectives. Clauzel AM Clin Rev Allergy; 1994; 12(1):43-64. PubMed ID: 7915191 [No Abstract] [Full Text] [Related]
30. Delivery systems for inhaled nitric oxide. Hess D; Ritz R; Branson RD Respir Care Clin N Am; 1997 Sep; 3(3):371-410. PubMed ID: 9390917 [TBL] [Abstract][Full Text] [Related]
31. New horizons in respiratory care: the pharmacology of inhaled aerosol drug therapy. Fink JB; Rau JL Respir Care; 2000 Jul; 45(7):824-5. PubMed ID: 10926378 [No Abstract] [Full Text] [Related]
32. Topical corticosteroids: a review of properties and principles in therapeutic use. Chaffman MO Nurse Pract Forum; 1999 Jun; 10(2):95-105. PubMed ID: 10542586 [TBL] [Abstract][Full Text] [Related]
33. Bioequivalence of metered-dose inhaled medications. Wong BJ; Hargreave FE J Allergy Clin Immunol; 1993 Sep; 92(3):373-9. PubMed ID: 8360387 [No Abstract] [Full Text] [Related]
34. [Drug treatment of chronic obstructive lung disease]. Geijer RM; Thomas S Ned Tijdschr Geneeskd; 1996 Jul; 140(27):1420-1. PubMed ID: 8766688 [No Abstract] [Full Text] [Related]
35. Inhaled corticosteroids as first-line therapy for asthma. Why they work--and what the guidelines and evidence suggest. Laurie S; Khan D Postgrad Med; 2001 May; 109(5):44-6, 49-52, 55-6. PubMed ID: 11381670 [TBL] [Abstract][Full Text] [Related]
36. Inhaled corticosteroids and growth velocity in children with asthma. Purucker M; Malozowski S J Pediatr; 1999 Aug; 135(2 Pt 1):264-6. PubMed ID: 10431250 [No Abstract] [Full Text] [Related]
37. The same glucocorticoid in brand-name products. Does increasing the concentration result in greater topical biologic activity? Stoughton RB; Wullich K Arch Dermatol; 1989 Nov; 125(11):1509-11. PubMed ID: 2817915 [TBL] [Abstract][Full Text] [Related]
38. Advances in inhaled technologies: understanding the therapeutic challenge, predicting clinical performance, and designing the optimal inhaled product. Bäckman P; Adelmann H; Petersson G; Jones CB Clin Pharmacol Ther; 2014 May; 95(5):509-20. PubMed ID: 24503626 [TBL] [Abstract][Full Text] [Related]